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“Open access to and wide use of research data will enhance
the quality and productivity of science systems worldwide.”1
PEN  MEDICINE  IS  AN  OPEN  ACCESS  JOURNAL
because we believe that free and timely access
to research results allows scientific knowledge
to be used by all those who need it, not just those who
can afford expensive journal subscriptions or user fees
for individual articles. But is access to the final polished
version of research enough? Could we do more to en-
courage the collaborative reuse and reanalysis of existing
data, or the verification of analyses? Could we move from
open access to open science?
O
Open science is emerging as a  collaborative and
transparent approach to research. It is the idea that all
data (both published and unpublished) should be freely
available, and that private interests should not stymie
its use by means of copyright, intellectual property
rights and patents. It also embraces open access pub-
lishing and open source software (rather than propri-
etary software, which limits others’ use of source code
and data analysis methods).2*
As the name seems to imply, there is no strict defini-
tion of open science, but it is inextricably linked to the
parallel movements of open access publication and open
source software.3  The varied effects of these related
movements are starting to emerge: there is an explosion
in the use of free software such as GNU/Linux and open
source software for other operating systems; more than
2600 journals have been converted to open access; and
studies are finding that articles published in open access
journals are cited more widely4  and that making data
openly accessible also increases citation advantage.5 
Open Medicine itself is using open source software to
underpin its journal management, blog, and electronic
publishing platform to exemplify what is technically fea-
sible for all journals (rather than just those with big
budgets) in scholarly publishing.  The Public Knowledge
Project, developer of Open Journal Systems (the open
source software we use for journal management) has also
recently   developed   Lemon8-XML  —  a   program   to
automate the conversion of text document formats to
publishing layout forms such as XML — ensuring that text
is labelled in a way that enables meaningful computer
searching of text  (see  http://pkp.sfu.ca/?q=ojs  ). For
example, it allows us to tag the date of publication and
author names as distinct fields so that computers can
search   and   find   data   that   would   usually   appear   as
unrecognizable text. In addition to its potentially powerful
contribution to data searching, Lemon8 has significant
resource implications for the many journals where XML
conversion is currently done manually or with proprietary
software.
There is wide institutional support for “open” initia-
tives. Various funding agencies mandate researchers to
make their findings available in an open access forum.6,7
The   recent   Canadian   Institutes   of   Health   Research
(CIHR) draft policy on access to CIHR-funded research
outputs  also requires  researchers  to state  how they
intend to make their research accessible to others, with
specific   reference   to   final   research   data     (“factual
information that is necessary to replicate and verify re-
search results”), original data sets, data sets that are too
large to be included in a peer-reviewed publication, and
any other data sets supporting the research publication.6 
Data-sharing has also garnered international sup-
port. In 2004 the Organisation for Economic Co-opera-
tion and Development (OECD) determined that “Coor-
dinated efforts at national and international levels are
needed to broaden access to data from publicly funded
research and contribute to the advancement of scientific
research and innovation.”1  They subsequently devel-
oped the Declaration on Access to Research Data from
Public Funding (Annex 1)1 and recently published a set
of guidelines outlining principles that would facilitate
cost-effective access to digital research data from public
funding.8 
What kinds of advantages would an initiative like
data-sharing   offer?   For   a   start,   data-sharing   opens
opportunities for the creative reanalysis of data. Most
researchers have had the experience of working single-
mindedly with neither the inspiration nor the time to
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explore alternative ways to look at their data. Sharing
data  with   other  researchers   with   different   research
expertise   may   give   rise   to   new   insights,   validated
findings, or supported and strengthened conclusions. A
changing   attitude   to   transparency   in   research   also
supports data-sharing: encouraging openness in science
promotes integrity, reduces the potential for scientific
fraud, and fosters public faith in scientific endeavour. 
A recent instance where problems might have been
averted was the fraudulent publication of two high-
profile papers on stem cell research.9,10 The publishing
journal, Science, subsequently convened a committee to
review   editorial   procedures.11  The   committee   rec-
ommended that more extensive information be includ-
ed in the published supporting material and asserted
that primary data are essential and should therefore be
made available to reviewers and readers (http://www.    -   
sciencemag.org/cgi/content/full/314/5804/1353/DC1)
In a climate where publication and prestige are closely
linked and the gains of publication can be great, data-
sharing offers a concrete way to monitor and ensure sci-
entific veracity.
It could also be argued that there is an ethical obliga-
tion to patients and funding agencies (and to taxpayers)
with a stake in scientific research to maximize the
benefit to study subjects, who often participate at some
personal risk, and to put to best use the money spent on
research. These are also opportunity costs to consider:
the human subjects who might have volunteered for a
different trial, and the funding that could have been
spent   elsewhere,   on   other   research   or   on   health
services. Thus, the limitations on resources provide
another good reason for data-sharing. 
Of course, some researchers find the idea of sharing
data difficult. They may be concerned that others may
find flaws in an analysis or gain benefit from data that
were difficult or time-consuming to obtain. There may
also be concerns about proprietary or classified data,
the   confidentiality   of   patient   data,   the   failure   to
properly   attribute   data   sources   or   ideas,   or   the
possibility that one’s research report may be “scooped.”
For the most part these arguments can be countered
quite easily: Surely we would want to know if we have
made errors, or should be flattered if others think our
ideas worthy of replication? With respect to attribution,
various options are being considered. Open licensing —
as with the Creative Commons license used by  Open
Medicine (see http://creativecommons.org/licenses/by-
nc-sa/2.5/ca/) — is one way of dealing with issues such
as intellectual property rights, allowing those who pro-
vide the original data to retain control over what others
do with their work.3 Creative Commons and the affiliat-
ed   Science   Commons   Project   are   working   hard   to
identify and simplify these kinds of barriers.12 
The practice of open data-sharing isn’t as unlikely as
one might think. Recent agreements for data-sharing in
genetic science allowed the development of the Human
Genome Project, while Jean-Claude Bradley and his
team of chemistry researchers post their results on the
Internet every day  under the banner of Open Notebook
Science (http://usefulchem.wikispaces.com/). Using a
freely accessible URL, anyone can access their laborato-
ry findings and validate, confirm or repudiate their re-
sults. The team also ensure that their findings are in-
dexed on common search engines. Importantly, posting
their results like this means that information such as
negative or inconclusive results or results that don’t fit
into published manuscripts are also posted.2 
Initiatives such as these will become increasingly im-
portant as data mining technologies become more so-
phisticated. With automated computer searching it will
be vital to have original data available so that data can
be searched and linked in a manner that allows the nov-
el uses of existing research. The development of the se-
mantic Web (searching by linking ideas rather than just
words   or   phrases)  offers   a   critical   step   toward
generating new research hypotheses.13 
Open Medicine is following the lead of PLoS Medicine
(http://journals.p    los.org/plosmedicine/policies.php    
#sharing) and the reproducible research policy of the
Annals of Internal Medicine.14 Although the latter was
initiated to support research integrity, it also supports a
broader data-sharing agenda. We now ask authors to
indicate   their   willingness   to   share   their   protocols,
datasets, and the statistical codes used for their analysis
with  other authors, and  we  encourage  authors who
publish secondary analyses to use the same Creative
Commons license that we use. Open Medicine will not
handle datasets and other such material directly, but by
publishing our authors’ willingness to share their original
data we hope to encourage fruitful collaboration. 
Authors who do not choose to submit these data will
not be penalized: we recognize that the acceptance of
data-sharing needs time to grow and develop in the
scientific community, and we welcome debate and dia-
logue as we develop our policy on data-sharing. We also
need to find ways to deal with some of the problems of
data-sharing, such as how to notify other researchers
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(or computers that are data-mining) about problems
with the data (e.g., in its collection, biases, potential
confounders.) and ways to manage original datasets in
large databases. Data security, managing data requests
and monitoring their appropriate use are other issues
that need attention. Perhaps institutions will begin to
archive original datasets in the same way that they are
beginning to archive their researchers’ publications?
Google   has   recently   started   to   help   researchers
exchange very large datasets (up to 120 terabytes) at no
charge provided that the data have no copyright or
licensing   restrictions   (www.earlham.edu/~peters/fos/
news    letter    /01-02-08.htm    #2007    ). These sorts of options
could   be   more   efficient   than   multiple   journals
developing their own data repositories.
However its ways and means evolve, an inexorable
drive to make science truly open is clear. Indeed, we be-
lieve the debate isn’t about whether we will share data
in the future but, rather, about  how  we will share it.
Perhaps future researchers will be funded for collecting
data with the understanding that all raw data will be de-
posited in public archives? Perhaps journal editors will
require data deposition as a requirement of publication
in the same way that they introduced clinical trial regis-
tration in 2004 ( www.icmje.org/clin_trialup.htm)?
Choosing to share data published in Open Medicine
gets to the heart of why we believe research is impor-
tant:   to   encourage   knowledge   production   and   dis-
semination, with the ultimate aim of improving health.
Allowing other researchers access to the data that you
have collected considerably extends its value, and an
open license encourages ongoing open access to data
and the knowledge derived from it. By making their
data “open,” researchers choose to build a stronger
research   base,   stimulate   debate   and   dialogue   and
promote public confidence in our published research. 
*Open source software ensures that source code is freely available and can
be used, changed, improved or redistributed, encouraging code sharing
and code integrity (http://en.wikipedia.org/wiki/Open_source_software).
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